The Motley Fool Discussion Boards
Politics & Current Events / Health Care Reform
|Subject: Re: The tyranny of ObamaCare||Date: 10/12/2012 4:10 PM|
|Author: fleg9bo||Number: 3958 of 4375|
What distinguishes the IPAB from the Environmental Protection Agency or the Federal Drug Administration is that those agencies give affected parties opportunities to weigh in before issuing their rules. This board would not be required to offer any avenue for patients and providers to air their concerns, nor could its decisions be challenged in court. Coaxing coverage out of heartless private insurers will seem like a piece of cake compared to confronting this all-powerful bureaucracy, which allows neither access nor appeal.
The IPAB's proposals would automatically become law unless Congress came up with its own equivalent spending cuts -- or both houses, including a three-fifths majority in the Senate, waived it and the president signed the waiver. This is an exceedingly high hurdle that would effectively turn the IPAB into a super legislature. Under the constitution, the legislative power – the supreme power – is lodged in Congress along with a democratic check. Courts avoid the democratic check but forego legislative powers. But no government entity, not even the Federal Reserve, gets unchecked legislative powers. This is what the IPAB will have, contravening the core of constitution's scheme of checks and balances.
Medicare spending is a pressing problem, no doubt. But the IPAB is a cure worse than the disease. It thwarts seniors' treatment options, providers' independence, and the constitutional balance of powers. The more Romney makes it an issue during his campaign, the more likely that the IPAB itself will be thwarted, whether he ends up in White House or not.
If Romney does nothing more than get rid of the IPAB, either directly or indirectly, then he will have ended up saving the lives of people you know, if not you yourselves. As surely as Democrats want to run your lives, the IPAB will in the near future deny life-saving and pain-relieving treatment that is very accessible today.
|Copyright 1996-2016 trademark and the "Fool" logo is a trademark of The Motley Fool, Inc. Contact Us|